President and Chief Scientific Officer Cellecta Inc. California, 94043
Cellecta's DriverMap Adaptive Immune Receptor (AIR) Profiling Assay offers a breakthrough solution for comprehensive TCR and BCR repertoire analysis in both bulk and single-cell samples. This innovative technology provides researchers with sensitive, reliable, and cost-effective data for target discovery and validation in cancer, infectious disease, vaccine research, and more. By overcoming the limitations of existing complex and expensive methods, the AIR Profiling Assay enables deeper insights into disease mechanisms and will accelerate the development of novel therapeutics and diagnostics. Case studies from collaborators demonstrate the assay's impact across multiple fields of immunology research.
